CVMP opinions on veterinary medicinal products

Under Regulation (EU) 2019/6, the Committee adopted, by consensus, a positive opinion for a marketing authorisation for Yurvac RHD, from Laboratorios Hipra, S.A., a new vaccine for the active immunisation of rabbits from 30 days of age onwards to reduce mortality of rabbit haemorrhagic disease (RHD) caused by classical RHD virus (RHDV) and variant strains (RHDV2), including highly virulent strains.

The Committee adopted by consensus a positive opinion for a variation requiring assessment for Tessie (tasipimidine) concerning the amendment of the product information with regard to the interactions with other medicinal products.

The Committee adopted by consensus a positive opinion for a grouped variation requiring assessment for NexGard Combo (esafoxolaner/eprinomectin/praziquantel) concerning the addition of two new therapeutic indications for persistent tick killing activity against Ixodes hexagonus and for persistent tick killing…